It is now widely accepted that inflammation is critical in cardiovascular diseases (CVD).
Here, studies are being conducted on how cyclic GMP-AMP synthase (cGAS), a component …

Patients with preexisting cardiovascular disease or those at high risk for developing the
condition are often offered exercise as a form of therapy. Patients with cancer who are at an …

Nanomedicine is an innovative field that merges nanotechnology with medicine, aiming to
enhance diagnosis, treatment, and prevention of diseases at the molecular level. This …

Cardiovascular disease (CVD) is the leading cause of death in the world, with a high
incidence and a youth-oriented tendency. RNA modification is ubiquitous and indispensable …

The poor efficiency and drastic adverse effects of current cancer therapies entail a radical
shift in treatment paradigms, which require developing cutting-edge therapeutics in …

Implementing Single-cell RNA sequencing (scRNA-seq) has significantly enhanced our
comprehension of cardiovascular diseases (CVDs), providing new opportunities to …

Cardiovascular disease is the leading cause of death, medical complications, and
healthcare costs. Although recent advances have been in treating cardiovascular disorders …

The achievement of genome-wide association studies (GWAS) has rapidly progressed our
understanding of the etiology of coronary artery disease (CAD). It unlocks new strategies to …

Cardiovascular diseases (CVDs) are still leading to a significant number of deaths
worldwide despite the remarkable advancements in medical technology and pharmacology …

Although non-toxic nanoscale materials are widely employed for different healthcare
applications, their performance is still considerably limited. In this paper, various approaches …